INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
64 hedge funds and large institutions have $53.5M invested in Infinity Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
64
Holders Change
-2
Holders Change %
-3.03%
% of All Funds
1.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
15
Reduced
15
Closed
16
Calls
$654K
Puts
$135K
Net Calls
+$519K
Net Calls Change
+$358K
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$10.4M |
| 2 |
First Eagle Investment Management
New York
|
+$955K |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
+$787K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$378K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$371K |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.54M |
| 2 |
GTC
Ghost Tree Capital
New York
|
-$3.68M |
| 3 |
MWNA
Marshall Wace North America
New York
|
-$791K |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$747K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$585K |
